David S. Stephens, MD; M. Juliana McElrath, MD, PhD
free access
has active quiz
JAMA. 2020;324(13):1279-1281. doi:10.1001/jama.2020.16656
This Viewpoint reviews what is known about acute and long-term B-cell, antibody, and T-cell responses to SARS-CoV-2 infection and explains how each are implicated in vaccine candidates likely to be effective and durably protective again COVID-19.
Kyle Thomson, JD, MPH; Herschel Nachlis, PhD
free access
has active quiz
has multimedia
has audio
JAMA. 2020;324(13):1282-1283. doi:10.1001/jama.2020.16253
This Viewpoint uses the FDA’s Emergency Use Authorization (EUA) of hydroxychloroquine for COVID-19 treatment to emphasize the costs of premature regulatory authorizations to public health and trust, and proposes the use of advisory committees, requirements for postmarketing surveillance, and adherence to standards of transparency for any future EUAs.
-
Conversations with Dr Bauchner:
Coronavirus Update With Michael T. Osterholm, PhD, MPH
Jerry Avorn, MD; Aaron Kesselheim, MD, JD, MPH
free access
has active quiz
has multimedia
has audio
JAMA. 2020;324(13):1284-1285. doi:10.1001/jama.2020.17101
This Viewpoint reviews the enormous political and public pressures the FDA is likely to be under in fall 2020 to provide emergency authorization or approval of candidate COVID-19 vaccines, and urges adherence to existing science-based protocols for approval to ensure vaccine safety and acceptance and thus protect the public’s health.
-
Conversations with Dr Bauchner:
Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency
-
Conversations with Dr Bauchner:
Coronavirus Update With Michael T. Osterholm, PhD, MPH
-
Editorial
Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine
Howard Bauchner, MD; Preeti N. Malani, MD, MSJ; Joshua Sharfstein, MD
-
Conversations with Dr Bauchner:
COVID-19 Vaccine Approval and the FDA
-
Conversations with Dr Bauchner:
Coronavirus Update With Michael T. Osterholm, PhD, MPH
-
Conversations with Dr Bauchner:
Coronavirus Q&A With Anthony Fauci, MD – September 25, 2020
-
Conversations with Dr Bauchner:
Coronavirus Update With Anthony Fauci - October 28, 2020
-
Conversations with Dr Bauchner:
Coronavirus Vaccine Update With Anthony Fauci
Adrian Brady, MB; James Brink, MD; John Slavotinek, MB
JAMA. 2020;324(13):1286-1287. doi:10.1001/jama.2020.14930
This Viewpoint discusses the importance of transitioning radiology from a volume-based to a value-based practice and specialty, starting from within with an effort by radiologists to help define and create that value for referring clinicians and the patients and health care systems they serve.
Leah I. Leinbach, DMD, MPH; Amber Willink, PhD
JAMA. 2020;324(13):1288-1289. doi:10.1001/jama.2020.3003
This Viewpoint discusses the need to expand Medicare benefits to include coverage for oral health services given the inextricable connection between diseases of the mouth, gums, and teeth and systemic disease, such as with stem cell transplants and immunosuppression, prosthetic heart valves, and bisphosphonate use.